“…The dispersed lutea cells were seeded at 3 × 10 6 cells/culture well (24-well polystyrene plate, Sigma-Aldrich) in attachment serum media (1 mL/well; DMEM supplemented with 10% (v/v) heat-inactivated charcoal stripped fetal bovine serum (CS-FBS; Avantor/VWR) and 5000 µg/mL penicillin/streptomycin (Sigma-Aldrich)) and incubated for 24 h in a humidified atmosphere of 5% CO 2 in air at 37 • C to equilibrate the cells to the culture condition, allow aggregation, and promote adherence. Following the 24 h incubation, attachment serum media were aspirated and replaced with culture media (1 mL/well; DMEM, 0.1% (w/v) BSA, 2.0% (v/v) CS-FBS, 0.5 mM ascorbic acid, and 5000 µg/mL penicillin/streptomycin) containing recombinant porcine adiponectin (RD572023100, BioVender, Candler NC) at 1 µg, 3 µg, 6 µg (n = 3 wells/dose), or without adiponectin, 0 µg (control; n = 3 wells), for 24 h in a humidified atmosphere of 5% CO 2 in air at 37 • C. The range in culture doses of adiponectin was based on reported follicular fluid concentrations of adiponectin [36], plasma concentrations [25], and adiponectin-cultured endothelial and ovarian cells [16,26]. The inclusion of CS-FBS in the culture media provides an environment that enhances cell viability and supports angiogenic-related processes [37].…”